# Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

> **NCT02534688** · PHASE4 · COMPLETED · sponsor: **King Chulalongkorn Memorial Hospital** · enrollment: 50 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** LNG-IUS
- **DRUG:** DMPA

## Key facts

- **NCT ID:** NCT02534688
- **Lead sponsor:** King Chulalongkorn Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02534688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02534688, "Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02534688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*